{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:07:04Z","timestamp":1756426024947,"version":"3.44.0"},"reference-count":27,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1080\/028418699431393","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:24:36Z","timestamp":1027686276000},"page":"323-328","source":"Crossref","is-referenced-by-count":9,"title":["Biokinetics of the Monoclonal Antibodies MOv 18, OV 185 and OV 197 Labelled with<sup>125<\/sup>I According to the m-MeATE Method or the Iodogen Method in Nude Mice with Ovarian Cancer Xenografts"],"prefix":"10.2340","volume":"38","author":[{"family":"H\u00e5kan Andersson, Sture Lindegren, T","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3109\/02841869309096130","volume":"32","author":"Maraveyas A","year":"1993","journal-title":"Acta Oncol"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bjc.1993.349","volume":"68","author":"Hird V","year":"1993","journal-title":"Br J Cancer"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1088\/0031-9155\/41\/10\/005","volume":"41","author":"Vaidyanathan G","year":"1996","journal-title":"Phys Med Biol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ijc.2910500324","volume":"50","author":"Molthoff CFM","year":"1992","journal-title":"Int .1- Cancer"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/hyb.1995.14.121","volume":"14","author":"Syrigos KN","year":"1995","journal-title":"Hybridoma"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0959-8049(94)00454-D","volume":"31","author":"Crippa F","year":"1995","journal-title":"Eur J Cancer"},{"key":"CIT0007","first-page":"196","volume":"17","author":"Nustad K","year":"1996","journal-title":"Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 Workshop. Tumor Biol"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000217996","volume":"17","author":"Nap M","year":"1996","journal-title":"Tumor Biol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004347-199101000-00002","volume":"10","author":"Boerman OC","year":"1991","journal-title":"Int .1- Gyn Path"},{"key":"CIT0010","first-page":"724","volume":"27","author":"Crippa F","year":"1991","journal-title":"Radioimmunoscintigra-phy of ovarian cancer with the M0v18 monoclonal antibody. Eur J Cancer"},{"key":"CIT0012","first-page":"422","volume":"27","author":"Hagan PL","year":"1986","journal-title":"J Nucl Med"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-5347(17)37758-3","volume":"146","author":"Chiou RK","year":"1991","journal-title":"J Urol"},{"key":"CIT0014","first-page":"297","volume":"39","author":"Miotti S","year":"1987","journal-title":"Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int .1-Cancer"},{"key":"CIT0015","first-page":"5329","volume":"51","author":"Campbell IG","year":"1991","journal-title":"Cancer Res"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0969-8051(98)00033-X","volume":"25","author":"Lindegren S","year":"1998","journal-title":"Nucl Med Biol"},{"key":"CIT0017","first-page":"77","volume":"72","author":"Lindmo T","year":"1984","journal-title":"Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0090-8258(92)90302-Y","volume":"45","author":"Muto MG","year":"1992","journal-title":"Gynecol Oncol"},{"key":"CIT0020","first-page":"150","volume":"23","author":"Schneider-Galicke E","year":"1992","journal-title":"Analysis of cytotoxicity of 1311-labelled 0C125 F(ab')2 on human epithelial ovarian cancer cell lines. Radiother Oncol"},{"key":"CIT0021","first-page":"368","volume":"32","author":"Manetta A","year":"1989","journal-title":"Therapeutic effect of radiolabeled antibody on human ovarian cancer xenografts in nude mice. Gynecol Oncol"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.2910510326","volume":"51","author":"Miotti S","year":"1992","journal-title":"Int J Cancer"},{"key":"CIT0024","first-page":"2169","volume":"15","author":"Boerman OC","year":"1995","journal-title":"Tumour targeting of the anti-ovarian car-cinoma X anti-CD3\/TCR bispecific monoclonal antibody OC\/ TR and its parenteral MOv18 antibody in experimental ovarian cancer. Anticancer Res"},{"key":"CIT0025","first-page":"677","volume":"65","author":"Molthoff CFM","year":"1992","journal-title":"Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies 0C125, OV-TL3, and 139H as IgG and F(a1:02 fragments in experimental ovarian cancer. Br J Cancer"},{"key":"CIT0026","first-page":"457","volume":"73","author":"Kievit E","year":"1996","journal-title":"Comparison of the monoclonal antibodies 17-1A and 323\/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts. Br J Cancer"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01742312","volume":"34","author":"Molthoff CFM","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0883-2889(89)90131-7","volume":"6","author":"Garg PK","year":"1989","journal-title":"Appl Radiat Isot Int J Radiat Appl Instrum Part A"},{"key":"CIT0029","first-page":"1446","volume":"48","author":"Zalutsky MR","year":"1988","journal-title":"Cancer Res"},{"key":"CIT0030","first-page":"5543","volume":"49","author":"Zalutsky MR","year":"1989","journal-title":"Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N. succinimi-dyl 3-(tri-n-butylstannyl)benzoate. Cancer Res"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/028418699431393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:05:43Z","timestamp":1756404343000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/32020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1080\/028418699431393"],"URL":"https:\/\/doi.org\/10.1080\/028418699431393","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"type":"print","value":"0284-186X"},{"type":"electronic","value":"1651-226X"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}